PATENT CLAIM ANALYSIS

Application Number: 16000467
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
The invention relates to novel strategies for the treatment of cancer patients based on a combination of an opioid receptor agonist and an anticancer compound.

Claim (Index 30):
The method according to  claim 31  wherein the patient suffers from a neoplasm selected from the group consisting of pancreatic carcinoma, hepatoblastoma, colon carcinoma, small cell lung cancer, melanoma, mamma carcinoma, ovarian carcinoma, prostate carcinoma, glioblastoma, acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, pro-forms of leukemia, hairy cell leukemia, Hodgkin's disease, Non-Hodgkin lymphoma, glioblastoma-initiating stem cells, tumour stem cells and multiple myeloma.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10835511', '13338809', '15920486', '13907035', '14427426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.800738976605645
- 35 USC 102 Novelty (BERT): 0.5153629456232444
- Combined Prediction Score: 0.7722013735074049
- Mean Citation Score: 292.329026
- Max Citation Score: 308.32446
- Similarity Product: 224.7127652656889

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test